GILEAD SCIENCES, INC. (GILD)
Healthcare › Biological Products, (No Diagnostic Substances)
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 168% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- Strong ROE of 33.4% with 26.1% net margin
- Dividend yield of 2.3%
GILEAD SCIENCES, INC. (GILD) is a Healthcare company operating in Biological Products, (No Diagnostic Substances), listed on the NASDAQ , with a market capitalisation of $166.7 billion . Key value metrics: P/E ratio 22.0, P/B ratio 7.34, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
GILEAD SCIENCES, INC. — Fundamental Analysis Summary
GILEAD SCIENCES, INC. (GILD) is currently trading 168% above its Graham Number of $50.12, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 22.0x.
On financial health, GILD shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 33.4% (sector average: -19.8%), and elevated leverage with a debt-to-equity ratio of 1.22.
StockPik's composite Value Score for GILD is 75/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
GILD reports a high gross margin of 78.7% (sector average: 33.5%) and a strong operating margin of 30.7%.
GILD shows revenue growing at 2% year-over-year, with earnings growing at 1,673%.
GILD pays a modest dividend yield of 2.3%.